June 21, 2021
Entwistle & Cappucci LLP and Wolf Haldenstein Adler Freeman & Herz LLP are competing in Maryland federal court to represent a proposed class of investors in a consolidated action claiming that biopharmaceutical company Emergent BioSolutions Inc. misled the public about how prepared it was to handle a pair of high-profile deals to manufacture COVID-19 vaccines.
June 02, 2021
Emergent Biosolutions and its top executives were hit with a proposed class action Wednesday brought by an investor alleging misrepresentations and omissions concerning quality control problems at the company's facility in Maryland culminated in the destruction of up to 100 million doses of Johnson & Johnson and AstraZeneca COVID-19 vaccines.